IL304381A - Type 1 heterodimeric membrane proteins and methods of using them - Google Patents

Type 1 heterodimeric membrane proteins and methods of using them

Info

Publication number
IL304381A
IL304381A IL304381A IL30438123A IL304381A IL 304381 A IL304381 A IL 304381A IL 304381 A IL304381 A IL 304381A IL 30438123 A IL30438123 A IL 30438123A IL 304381 A IL304381 A IL 304381A
Authority
IL
Israel
Prior art keywords
heterodimers
methods
type
membrane proteins
proteins
Prior art date
Application number
IL304381A
Other languages
English (en)
Hebrew (he)
Inventor
Tamir Ami
L Tykocinski Mark
BREMER Edwin
Original Assignee
Kahr Medical Ltd
Univ Jefferson
Tamir Ami
L Tykocinski Mark
BREMER Edwin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kahr Medical Ltd, Univ Jefferson, Tamir Ami, L Tykocinski Mark, BREMER Edwin filed Critical Kahr Medical Ltd
Publication of IL304381A publication Critical patent/IL304381A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL304381A 2021-01-13 2023-07-10 Type 1 heterodimeric membrane proteins and methods of using them IL304381A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163136687P 2021-01-13 2021-01-13
US202163139331P 2021-01-20 2021-01-20
PCT/IL2022/050055 WO2022153307A1 (en) 2021-01-13 2022-01-13 Type i membrane proteins heterodimers and methods of use thereof

Publications (1)

Publication Number Publication Date
IL304381A true IL304381A (en) 2023-09-01

Family

ID=82447997

Family Applications (1)

Application Number Title Priority Date Filing Date
IL304381A IL304381A (en) 2021-01-13 2023-07-10 Type 1 heterodimeric membrane proteins and methods of using them

Country Status (10)

Country Link
US (1) US20240076346A1 (enExample)
EP (1) EP4277923A4 (enExample)
JP (1) JP2024503685A (enExample)
KR (1) KR20230169933A (enExample)
AU (1) AU2022208466A1 (enExample)
BR (1) BR112023013898A2 (enExample)
CA (1) CA3204707A1 (enExample)
IL (1) IL304381A (enExample)
MX (1) MX2023008351A (enExample)
WO (1) WO2022153307A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2769769C2 (ru) 2017-01-05 2022-04-05 Кахр Медикал Лтд. СЛИТЫЙ БЕЛОК SIRPα-4-1BBL И СПОСОБЫ ЕГО ПРИМЕНЕНИЯ
CN110536693B (zh) 2017-01-05 2023-12-22 卡尔医学有限公司 Pd1-41bbl融合蛋白及使用其的方法
US11566060B2 (en) 2017-01-05 2023-01-31 Kahr Medical Ltd. PD1-CD70 fusion protein and methods of use thereof
EP3820887A4 (en) 2018-07-11 2022-04-20 KAHR Medical Ltd. Pd1-4-1bbl variant fusion protein and methods of use thereof
KR102945860B1 (ko) 2018-07-11 2026-03-31 카 메디컬 리미티드 SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법
CN111454369A (zh) * 2020-04-10 2020-07-28 润方(长春)生物科技有限公司 一种用于制备异二聚物蛋白质的方法
US20250051410A1 (en) * 2021-12-23 2025-02-13 Kahr Medical Ltd. Lilrb polypeptides and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731168A (en) * 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
WO2014164519A1 (en) * 2013-03-12 2014-10-09 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for inhibiting the effects of amyloid beta oligomers
WO2016023001A1 (en) * 2014-08-08 2016-02-11 The Board Of Trustees Of The Leland Stanford Junior University Multispecific high affinity pd-1 agents and methods of use
CN113831417B (zh) * 2017-05-08 2024-10-01 上海津曼特生物科技有限公司 双特异性重组蛋白及其应用
CN107857819A (zh) * 2017-07-03 2018-03-30 江苏西迪尔生物技术有限公司 多功能融合蛋白及其应用
EP3908664A4 (en) * 2019-01-07 2023-01-25 Thomas Jefferson University MULTIFUNCTIONAL FUSION PROTEINS AND THEIR USES
EP3947460A4 (en) * 2019-03-26 2023-05-10 Forty Seven, Inc. MULTISPECIFIC AGENTS FOR TREATMENT OF CANCER
TWI760751B (zh) * 2019-05-29 2022-04-11 美商美國禮來大藥廠 Tigit及pd-1/tigit-結合分子
CN110128550B (zh) * 2019-05-30 2023-01-13 南京惟亚德生物医药有限公司 一种新型的同时阻断免疫检查点pd-l1和tigit的复制型溶瘤腺病毒和应用
US20220267409A1 (en) * 2019-07-11 2022-08-25 Kahr Medical Ltd. Heterodimers and methods of use thereof

Also Published As

Publication number Publication date
MX2023008351A (es) 2023-10-10
KR20230169933A (ko) 2023-12-18
WO2022153307A1 (en) 2022-07-21
AU2022208466A1 (en) 2023-08-17
JP2024503685A (ja) 2024-01-26
BR112023013898A2 (pt) 2023-10-31
AU2022208466A9 (en) 2024-07-11
CA3204707A1 (en) 2022-07-21
EP4277923A1 (en) 2023-11-22
US20240076346A1 (en) 2024-03-07
EP4277923A4 (en) 2025-01-22

Similar Documents

Publication Publication Date Title
IL304381A (en) Type 1 heterodimeric membrane proteins and methods of using them
IL277337A (en) Antibodies against alpha signal modulatory protein and methods of use
PL4232463T3 (pl) Białka fuzyjne interleukiny-2-fc i sposoby ich stosowania
IL287273A (en) Recombinant polyclonal proteins and methods of using them
DK4011908T5 (da) Ultralangtidsvirkende insulin-FC-fusionsproteiner og fremgangsmåder til anvendelse deraf
EP3802617A4 (en) MULTISPECIFIC BINDING PROTEINS AND METHODS OF USE THEREOF
EP3856787A4 (en) SIRPalpha BINDING PROTEINS AND METHODS OF USE THEREOF
EP3515490B8 (en) Antibodies against signal-regulatory protein alpha and methods of use
SG11202100320QA (en) Therapeutic preparations of gamma-delta t cells and natural killer cells and methods for manufacture and use
IL279587A (en) Protein tyrosine phosphatase inhibitors and methods of using them
SG11202006148UA (en) Multi-domain immunomodulatory proteins and methods of use thereof
SG11202013170RA (en) Pd1-4-1bbl variant fusion protein and methods of use thereof
MA51676A (fr) Protéines de fusion il-22 fc et procédés d'utilisation
SG11202013167UA (en) SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
DK4073098T3 (da) Ultralangtidsvirkende insulin-Fc-fusionsproteiner og fremgangsmåder til anvendelse
EP3980067A4 (en) ANTIBODY INTERLEUKIN FUSION PROTEIN AND METHODS OF USE
EP3265477A4 (en) DUAL SIGNALING PROTEIN (DSP) FUSION PROTEINS AND METHOD FOR THE USE THEREOF FOR THE TREATMENT OF DISEASES
IL283830A (en) A multigene structure for protein expression that modulates the immune system and methods of use
IL304228A (en) Sialidase-antibody-pd-1 fusion proteins and methods of using them
HK40104881A (en) Type i membrane proteins heterodimers and methods of use thereof
EP3814765A4 (en) PROTEIN UPtake MEMBRANE AND METHODS OF USE THEREOF
EP3794104A4 (en) CELL EXPANSION SYSTEM AND METHODS OF USING THE SAME
HK40046121A (en) Antibodies against signal-regulatory protein alpha and methods of use
HK40062139A (en) Multigene construct for immune-modulatory protein expression and methods of use
GB202315959D0 (en) Polymer and its use for analysing membrane proteins